Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03391960 · ClinicalTrials.gov registry record · NA
Passive Disinfection Cap Compliance Study
A NA study of Infection, Hospital, sponsored by Solventum US.
- Completed
- Registry status
- NA
- Development phase
- 165
- Enrollment target
- 1
- Study location
NCT03391960 is a NA study of Infection, Hospital that has completed, run by Solventum US. The registered enrollment target is 165 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03391960, a NA study of Infection, Hospital, has completed, sponsored by Solventum US.
- COMPLETED
- Registry status
- NA
- Development phase
- 165 participants
- Enrollment target
- 1
- Study location
Study Summary
Insertion and maintenance of central venous catheter (CVC) lines are common hospital procedures in patients, including those being treated for cancer. CVCs allow clinicians an access point for infusion of fluids, blood sampling, and measurements, decreasing the need for repeated needle sticks to the patient. However, bloodstream infections associated with CVCs (CLABSIs) are a serious complication, leading to significantly longer hospital stays, morbidity, and mortality. Keeping catheter ports disinfected reduces the risk of bloodstream infection; however, consistent and adequate maintenance and disinfection of the line can be difficult. The purpose of this study is to demonstrate that passive disinfecting caps can provide a patient safety practice that is easy for clinicians to follow, as well as providing easily auditable compliance, which may lead to lower CLABSI rates. The compliance rate for needleless connector disinfection will be evaluated after implementation of the passive disinfecting cap, and compared to the pre-intervention rate. The CLABSI rates before and after cap implementation will also be compared.
Conditions Studied
Interventions
- DEVICE Passive disinfection device
Study Locations (1)
Minnesota
- 3M HealthCare - Maplewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2018-04-01 |
| Est. Completion | 2018-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03391960
The ClinicalTrials.gov registry entry for NCT03391960 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Solventum US, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Infection, Hospital appearing as the primary indexed condition, and to 1 intervention - of which Passive disinfection device is the first listed.
NCT03391960 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT03391960 about?
NCT03391960 is a clinical study titled "Passive Disinfection Cap Compliance Study". Insertion and maintenance of central venous catheter (CVC) lines are common hospital procedures in patients, including those being treated for cancer. CVCs allow clinicians an access point for infusion of fluids, blood sampling, and measurements, decreasing the need for repeated needle sticks to the...
What is the current status of trial NCT03391960?
This trial is currently completed. It is a NA study. The enrollment target is 165 participants. The study started on 2018-04-01. Estimated completion is 2018-10-31.
What conditions does trial NCT03391960 study?
This clinical trial studies the following conditions: Infection, Hospital.
What interventions are being tested in trial NCT03391960?
The interventions under investigation include: Passive disinfection device (DEVICE).
Who is sponsoring clinical trial NCT03391960?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03391960 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.